Hypertension treatment in Republic of Korea — get 3 personalized clinic matches
Medically reviewed by
Fahad Mawlood
How it works
What's the Cost of Hypertension Diagnosis and Treatment in Republic of Korea?
| Republic of Korea | Turkey | Austria | |
|---|---|---|---|
| LDL Apheresis | ≈ $1,100 | ≈ $450 | ≈ $1,100 |
Best Hypertension Treatment Centers in Republic of Korea: 12 Verified Options and Prices
Ewha Womans University Medical Center
Paik Nam-sun
Get a Medical Assessment for Hypertension in Republic of Korea: Consult with Experienced Doctors Now
View all Doctors
Ahn Taehun
Dr. Ahn Taehun is a cardiologist (MD, PhD) and Director of a Cardiovascular Center. He specializes in coronary artery disease, including angina and myocardial infarction. He also treats hypertension, heart valve disease, heart failure, and hyperlipidemia. His expertise includes interventional cardiology, echocardiography, and cardiovascular imaging. He also manages atherosclerosis, arterial occlusive disease, dilated cardiomyopathy, and myocarditis.
He has held several leadership roles. He served as Chairman of the Board of the Korean Society of Interventional Cardiology (KSIC) and President of the Korean Society of Cardiology (KSC). He was Finance Director of the KSC. He led the Korean Vascular Intervention Society (KVIS) and the Korean Cardiovascular Complications Committee (KCCC) as President. He also chaired the Organizing Committee for ENCORE SEOUL (Endovascular & Coronary Revascularization).
Hwang Ui Seok
Dr. Hwang Ui Seok, MD, PhD, is a cardiologist. He is Director of the Arrhythmia Center at Myongji Hospital and a Clinical Professor of Cardiology. His expertise includes arrhythmias and syncope, radiofrequency catheter ablation, pacemakers and ICDs, and cardiac and vascular interventions. He also treats angina, heart failure, hypertension, and hyperlipidemia.
He earned his MD from Seoul National University. He completed his MS and PhD at the University of Ulsan. He finished his residency at Seoul National University Hospital. He trained as a fellow at Asan Medical Center. He also completed a research fellowship at the Cleveland Clinic in the United States. He previously served as a Clinical Assistant Professor at Severance Hospital, Yonsei University.
He is a member of the Korean Association of Internal Medicine and the Korean Society of Cardiology. His publications include a 2010 Circulation Journal paper on irrigated catheters for AF ablation and a 2007 Atherosclerosis paper on serial IVUS of ruptured plaques.
Oh Dongju
Dr. Oh Dongju, MD, PhD, is a cardiologist. He specializes in hypertension, hyperlipidemia, angina, myocardial infarction, valvular disease, dilated cardiomyopathy, and myocarditis. His work also covers atherosclerosis and arterial occlusive disease. He is skilled in echocardiography and cardiovascular imaging.
He completed a cardiology fellowship at Emory University School of Medicine. He also served as a Clinical Instructor at the Cornell University Weill Department of Medicine. He has held many leadership roles. He served as President, KSIC; Director of Publications, General Affairs, and Public Relations, KSC; Chairman, KACG; Board Member, Asan Heart Foundation; Vice President, KHA; Chairman, Division of Cardiology, KAIM; Vice President, NAMOK/KAMS; Governor, ACC Korea Chapter; and Member, the National Bioethics Committee.
Byung Hee Oh
Dr. Byung Hee Oh is a cardiologist at Incheon Sejong Hospital. He previously served as President of the Korean Society of Cardiology. Dr. Oh specializes in heart failure, coronary artery disease, and complex arrhythmias. He held leadership roles at Seoul National University Hospital. Dr. Oh has authored hundreds of peer-reviewed publications. He treats patients at Sejong Hospital, which sees over 400,000 annual visits.
- Former Head of the Division of Cardiology at Seoul National University.
- Performs radiofrequency ablation and carotid stenting.
- Received national honors for medical excellence and leadership.
- Focuses on preventive cardiology and hypertension management.
Share this content
Video Stories from Bookimed Patients
Anna Leonova
Expert Overview about Hypertension Treatment in Republic of Korea
What is the standard blood pressure target for treatment in Korea?
The standard blood pressure target in South Korea is less than 140/90 mmHg for most adults. The Korean Society of Hypertension maintains this baseline. High-risk patients with diabetes or cardiovascular disease typically require more intensive control. Experts often aim for targets below 130/80 mmHg in these cases.
- General population target: Standard clinical goal is less than 140/90 mmHg.
- High-risk groups: Cardiovascular disease patients target less than 130/80 mmHg.
- Diabetes management: Usual target is 140/85 mmHg or 130/80 mmHg.
- Home monitoring: Targets are lower at 135/85 mmHg for general hypertensive patients.
Bookimed Expert Insight: Quality indicators reflect the high standard of cardiology in Seoul. Asan Medical Center performs 45% of Korea's heart transplants and maintains 90% success rates. This volume suggests that clinics with Newsweek rankings often manage the most complex hypertension cases. Look for JCI-accredited centers like Severance Hospital for integrated cardiovascular care.
Patient Consensus: Patients note that Korean care teams strongly emphasize keeping daily home logs. Many report that doctors prioritize tighter control specifically to reduce the risk of stroke.
Which medications are most commonly prescribed for hypertension in Korea?
Hypertension treatment in South Korea primarily utilizes angiotensin receptor blockers (ARB) and calcium channel blockers (CCB). These drug classes cover over 75% and 60% of patients respectively. Local protocols favor these over ACE inhibitors to avoid common side effects like chronic dry cough.
- Dominant ARBs: Telmisartan and losartan are the most frequently prescribed angiotensin receptor blockers.
- Leading CCB: Amlodipine remains the primary calcium channel blocker used for blood pressure.
- Combination therapy: Dual therapy regimens using single-pill combinations apply to 44% of patients.
- Prescription frequency: Diuretics and beta-blockers serve 22% and 15% of treated cases respectively.
Bookimed Expert Insight: Data from top-tier institutions like Asan Medical Center and Seoul National University Hospital shows a heavy shift toward digitalization. These centers use advanced systems like BESTcare to track long-term medication adherence. This digital focus ensures that patients receiving complex dual therapies are monitored with higher precision than in traditional paper-based systems.
Patient Consensus: Patients note that doctors often start treatment with amlodipine or losartan due to their high availability. While these are effective, many emphasize checking for leg swelling or dizziness, especially when using high-dose combination pills.
Are lifestyle modifications part of Korea’s official hypertension guidelines?
Lifestyle modifications are a central pillar of the official Korean hypertension guidelines. The Korean Society of Hypertension mandates non-drug therapy for all patients. Specific recommendations prioritize sodium reduction to under 6g daily. Clinics implement these changes alongside medication or as a primary first-line treatment phase.
- Sodium limit: Guidelines restrict daily salt intake to less than 6g total.
- Dietary patterns: Doctors recommend Korean-style diets high in vegetables, fish, and legumes.
- Weight targets: Patients aim for a BMI below 25 for optimal pressure control.
- Treatment timing: Low-risk patients may undergo lifestyle changes for up to 3 months.
Bookimed Expert Insight: While many countries follow Western DASH diets, South Korea's top cardiology centers like Asan Medical Center integrate specialized nutritional counseling to modify high-sodium traditional staples. Our data shows that major Seoul facilities often use 24-hour ambulatory monitoring to verify if lifestyle shifts alone are sufficient before starting lifelong medication protocols.
Patient Consensus: Patients note that doctors strictly emphasize cutting salt from common foods like kimchi and ramyeon. Many recommend pairing these dietary changes with daily 30-minute walks to see significant blood pressure improvements.
Is home blood-pressure monitoring (HBPM) recommended for patients in South Korea?
Home blood-pressure monitoring is strongly recommended in South Korea for hypertension diagnosis and management. The Korean Society of Hypertension advises a 135/85 mmHg threshold for home readings. Using validated automated upper-arm devices helps identify masked hypertension and significantly improves long-term cardiovascular outcomes.
- Diagnostic threshold: Hypertension is confirmed if home averages reach 135/85 mmHg.
- Best practices: Measure BP 1–3 times per session twice daily.
- Optimal timing: Check within 1 hour of waking and before sleep.
- Device type: Use validated brachial arm cuffs instead of wrist monitors.
Bookimed Expert Insight: South Korea is a global cardiology hub where institutions like Severance Hospital and Asan Medical Center manage millions of patients. Our data shows a trend toward total digitalization in clinics like Seoul National University Bundang Hospital. For patients, this means home readings are no longer just for personal logs. They are increasingly integrated into digital healthcare systems for real-time specialist review.
Patient Consensus: Patients note that home monitoring reveals white-coat spikes often missed during short clinic visits. Many recommend calibrating your home cuff against the hospital device during your first appointment to ensure accuracy.
What proportion of Korean adults actually have their hypertension controlled?
Recent data shows 62.2% of Korean adults now maintain controlled blood pressure levels. This marks a significant national milestone in cardiovascular health. Rates remain highest among those receiving active medical treatment. Approximately 76% of hypertensive patients currently utilize blood pressure medication.
- Treatment success: Patients on medication achieve blood pressure control in 72% to 73% of cases.
- Awareness gap: Around 78.6% of adults are aware they have hypertension before starting treatment.
- Age disparity: Controlled rates for young adults aged 20–39 drop significantly to 32.9%.
- Senior outcomes: Adults over 65 years reach control rates approaching 60% through consistent monitoring.
Bookimed Expert Insight: Korea's high control rates correlate with extreme institutional specialization in cardiology. Facilities like Asan Medical Center perform 45% of the country's heart transplants. This concentrated expertise ensures that even complex, resistant hypertension cases benefit from protocols used in high-volume surgical centers. Patients should prioritize clinics with integrated cardiovascular centers for more precise 24-hour monitoring.